首页> 中文会议>2008第四届海河之滨心脏病学会议 >The effects Tirofiban on no-reflow in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention

The effects Tirofiban on no-reflow in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention

摘要

OBJECTIVES:To evaluate the effects of tirofiban on no-reflow in patients with acute myocardial infarction(AMD undergoing primary percutaneous intervention(PPCI).METHODS:58 consecutive AMI patients undergoing PPCI were divided into two groups randomly:patients in group B is treated with routine procedure of PCI;while group A is pretreatedwith Ttrofiban intravenous bolus 10ug.kg-1,followed by 0.15ug.kg-1.main-1 infusion,and then accepted the routine procedure of PCI.The rate of TIMI 3 grade flow,the corrected TIMI frame count(CTFC)of the two groups were evaluated,and also the left ventricular ejection fraction(LVEF)at thenty days and the in hospital mortality in the two groups were assessed.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号